CVS Health Ventures’ latest bet comes in. The company announced it led a $25 million strategic investment in Knownwell, a Boston-based obesity-care platform that treats weight management as a chronic condition — not a subscription business. Knownwell’s physician-led model is designed for payers and patients alike, and its expansion signals a deeper shift: the end of the GLP-1 land grab and the start of an outcomes-based phase of obesity care.
Why it matters now: if list prices compress toward $150, access parity rises and the competitive moat shifts from drug arbitrage to care integration.
1 comment
[ 1.7 ms ] story [ 9.7 ms ] threadWhy it matters now: if list prices compress toward $150, access parity rises and the competitive moat shifts from drug arbitrage to care integration.